Public Sector Pension Investment Board boosted its stake in Humana Inc. (NYSE:HUM – Free Report) by 13.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,222 shares of the insurance provider’s stock after acquiring an additional 600 shares during the quarter. Public Sector Pension Investment Board’s holdings in Humana were worth $1,654,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. CarsonAllaria Wealth Management Ltd. boosted its stake in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Creative Financial Designs Inc. ADV boosted its position in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the last quarter. Atwood & Palmer Inc. acquired a new stake in shares of Humana during the third quarter valued at about $29,000. Hantz Financial Services Inc. acquired a new stake in shares of Humana during the second quarter valued at about $35,000. Finally, Family Firm Inc. purchased a new stake in shares of Humana during the second quarter worth about $37,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have weighed in on HUM. Deutsche Bank Aktiengesellschaft lowered their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Leerink Partnrs lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Royal Bank of Canada reduced their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $315.86.
Humana Trading Down 1.7 %
Shares of NYSE:HUM opened at $283.06 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $273.44 and its 200 day moving average price is $327.75. The company has a market cap of $34.08 billion, a PE ratio of 25.07, a P/E/G ratio of 2.29 and a beta of 0.53. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $498.17.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Sell-side analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current year.
Humana Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What is the Nasdaq? Complete Overview with History
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Stock Dividend Cuts Happen Are You Ready?
- BlackRock Makes Waves With $12B Private Credit Acquisition
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.